Market Movers

Amcor plc’s Stock Price Soars to $9.80, Marking a Stellar Increase of +9.62%

Amcor plc (AMCR)

9.80 USD +0.86 (+9.62%) Volume: 25.82M

Amcor plc’s stock price soars to $9.80, marking a significant trading session increase of +9.62% with a robust trading volume of 25.82M. The packaging giant’s YTD performance also shows a positive trajectory, up by +1.66%, indicating a promising investment opportunity.


Latest developments on Amcor plc

Amcor’s (AMCR) Q3 earnings surpassed expectations, despite a year-on-year dip in revenues due to lower volumes, leading to a rise in its stock price. The packaging company also raised its full-year guidance, predicting further earnings growth. This positive outlook, combined with the announcement of the largest dairy production capacity expansion in the history of Amcor Flexibles North America, resulted in a jump in the company’s Australia-listed shares. Despite overall losses on the day, Amcor’s stock outperformed the market, further buoyed by the unveiling of sustainable packaging for Huggies nappies in Peru.


A look at Amcor plc Smart Scores

FactorScoreMagnitude
Value2
Dividend5
Growth4
Resilience2
Momentum3
OVERALL SMART SCORE3.2

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Amcor PLC, a packaging company known for its wide range of flexible and rigid packaging solutions, has received varying Smart Scores across different factors. While scoring high in areas like dividend and growth potential, the company falls short in terms of value and resilience. With a strong momentum score, Amcor seems to be on a positive trajectory for future growth and development.

Despite facing challenges in certain areas, Amcor’s high dividend and growth scores indicate promising long-term prospects for the company. As a key player in the packaging industry, serving customers globally with a focus on sectors like food, beverage, pharmaceuticals, and medical, Amcor is well-positioned to capitalize on its strengths and opportunities for continued success in the market.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars